The role of miR-26 in tumors and normal tissues (Review)

  • Authors:
    • Jie Gao
    • Qing-Guang Liu
  • View Affiliations

  • Published online on: September 5, 2011     https://doi.org/10.3892/ol.2011.413
  • Pages: 1019-1023
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

miR-26, a functional miRNA, has received much attention from researchers in recent years. miRNAs may play crucial roles in numerous biological processes such as cell proliferation, apoptosis, tumorigenesis at different stages of non-tumor diseases, growth and development of normal tissues, and other biological processes. The expression of miR-26 has been found to be specific to different biological processes. Furthermore, its expression is frequently abnormal in tumors, indicating that miR-26 may play significant roles in tumor formation. Various reports exist regarding miR-26 involvement in non-tumor diseases, as well as the process of growth and development of normal tissues. In this review, we report findings of recent studies on the expression of miR-26 in different types of diseases and the process of growth and development and its predicted target genes in different tissue types. In conclusion, it is useful for researchers to understand the role of miR-26 in different biological processes.

References

1 

Liu X, Chen Z, Yu J and Zhou X: MicroRNA profiling and head and neck cancer. Comp Funct Genomics. 837514:1–11. 2009. View Article : Google Scholar : PubMed/NCBI

2 

Lewis BP, Shih I, Jones-Rhoades MW, Bartel DP and Burge CB: Prediction of mammalian microRNA targets. Cell. 115:787–798. 2003. View Article : Google Scholar : PubMed/NCBI

3 

Lewis BP, Burge CB and Bartel DP: Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 120:15–20. 2005. View Article : Google Scholar : PubMed/NCBI

4 

Xiaohui X, Jun L, Kulbokas EJ, et al: Systematic discovery of regulatory motifs in human promoters and 3′ UTRs by comparison of several mammals. Nature. 434:338–345. 2005.

5 

Williams AE: Functional aspects of animal microRNAs. Cell Mol Life Sci. 65:545–562. 2008. View Article : Google Scholar : PubMed/NCBI

6 

Stefani G and Slack FJ: Small non-coding RNAs in animal development. Nat Rev Mol Cell Biol. 9:219–230. 2008. View Article : Google Scholar : PubMed/NCBI

7 

Filipowicz W, Bhattacharyya SN and Sonenberg N: Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet. 9:102–114. 2008. View Article : Google Scholar : PubMed/NCBI

8 

Bartel DP: MicroRNAs: genomics, biogenesis, mechanism and function. Cell. 116:281–297. 2004. View Article : Google Scholar : PubMed/NCBI

9 

Bushati N and Cohen SM: microRNA functions. Annu Rev Cell Dev Biol. 23:175–205. 2007. View Article : Google Scholar

10 

Chang TC and Mendell TJ: microRNAs in vertebrate physiology and human disease. Annu Rev Genomics Hum Genet. 8:215–239. 2007. View Article : Google Scholar : PubMed/NCBI

11 

Kloosterman WP and Plasterk RHA: The diverse functions of microRNAs in animal development and disease. Dev Cell. 11:441–450. 2006. View Article : Google Scholar : PubMed/NCBI

12 

Ambros V: The functions of animal microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI

13 

Tong AW and Nemunaitis J: Modulation of miRNA activity in human cancer: a new paradigm for cancer gene therapy? Cancer Gene Ther. 15:341–355. 2008. View Article : Google Scholar : PubMed/NCBI

14 

Chen CZ: MicroRNAs as oncogenes and tumor suppressors. N Engl J Med. 353:1768–1771. 2005. View Article : Google Scholar : PubMed/NCBI

15 

Calin GA, Sevignani C, Dumitru CD, et al: Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad of Sci U S A. 101:2999–3004. 2004. View Article : Google Scholar : PubMed/NCBI

16 

Muinos-Gimeno M, Montfort M, Bayes M, Estivill X and Espinosa-Parrilla Y: Design and evaluation of single-nucleotide polymorphisms in microRNA genomic regions for association studies in human disease. Eur J Hum Genet. 18:218–226. 2010. View Article : Google Scholar : PubMed/NCBI

17 

Diederichs S and Haber DA: Sequence variations of microRNAs in human cancer: alterations in predicted secondary structure do not affect processing. Cancer Res. 66:6097–6104. 2006. View Article : Google Scholar : PubMed/NCBI

18 

Calin GA and Croce CM: MicroRNA signatures in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI

19 

Iorio Marilena V, Ferracin M, Liu CG, et al: MicroRNA gene expression deregulation in human breast cancer. Cancer Res. 65:7065–7070. 2005.PubMed/NCBI

20 

Wang G, Zhang H, He H, et al: Up-regulation of microRNA in bladder tumor tissue is not common. Int Urol Nephrol. 42:95–102. 2009. View Article : Google Scholar : PubMed/NCBI

21 

Maillot G, Lacroix-Triki M, Pierredon S, et al: Widespread estrogen-dependent repression of microRNAs in breast tumor cell growth. Cancer Res. 69:8332–8340. 2009. View Article : Google Scholar : PubMed/NCBI

22 

Zhang B, Liu XX, He JR, et al: Pathologically decreased miR-26a antagonizes apoptosis and facilitates carcinogenesis by targeting MTDH and EZH2 in breast cancer. Carcinogenesis. 32:2–9. 2010. View Article : Google Scholar : PubMed/NCBI

23 

Yu T, Wang XY, Gong RG, et al: The expression profile of microRNAs in a model of 7,12-dimethyl-benz[a]anthrance- induced oral carcinogenesis in Syrian hamster. J Exp Clin Cancer Res. 28:64–73. 2009.PubMed/NCBI

24 

Visone R, Pallante P, Vecchione A, et al: Specific microRNA are downregulated in human thyroid anaplastic carcinomas. Oncogene. 26:7590–7595. 2007. View Article : Google Scholar : PubMed/NCBI

25 

Ciarapica R, Russo G, Verginelli F, Donfrancesco A, Rota R and Giordano A: Deregulated expression of miR-26a and EZH2 in rhabdomyosarcoma. Cell Cycle. 8:172–175. 2009. View Article : Google Scholar : PubMed/NCBI

26 

Sandrine S, Lars B and Thomas W: Repressing the repressor: a new mode of MYC action in lymphomagenesis. Cell Cycle. 8:556–559. 2009. View Article : Google Scholar : PubMed/NCBI

27 

Kota J, Chivukula RR, O’Donnell KA, et al: Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell. 137:1005–1017. 2009. View Article : Google Scholar : PubMed/NCBI

28 

Ji J, Shi J, Budhu A, et al: MicroRNA expression, survival, and response to interferon in liver cancer. N Engl J Med. 361:1437–1447. 2009. View Article : Google Scholar : PubMed/NCBI

29 

Huse JT, Brennan C, Hambardzumyan D, et al: The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo. Genes and Dev. 23:1327–1337. 2009. View Article : Google Scholar : PubMed/NCBI

30 

Kim H, Huang W, Jiang X, Pennicooke B, Park PJ and Johnson MD: Integrative genome analysis reveals an oncomir/oncogene cluster regulating glioblastoma survivorship. Proc Natl Acad of Sci USA. 107:2183–2188. 2010. View Article : Google Scholar : PubMed/NCBI

31 

Padgett KA, Lan RY, Leung PC, et al: Primary billiary cirrhosis is associated with altered hepatic microRNA expression. J Autoimmun. 32:246–253. 2009. View Article : Google Scholar : PubMed/NCBI

32 

Rogler CE, LeVoci L, Ader T, Massimi A, Tchaikovskaya T, Norel R and Rogler LE: MicroRNA-23b cluster microRNA regulate transforming growth factor-beta/bone morphogenetic protein signaling and liver stem cell differentiation by targeting Smads. Hepatology. 50:575–584. 2009. View Article : Google Scholar : PubMed/NCBI

33 

Itoh T, Nozawa Y and Akao Y: MicroRNA-141 and -200a are involved in bone morphogenetic protein-2-induced mouse pre-osteoblast differentiation by targeting distal-less homeobox 5. J Biol Chem. 284:19272–19279. 2009. View Article : Google Scholar : PubMed/NCBI

34 

Wong CF and Tellam RL: MicroRNA-26a targets the histone methyltransferase enhancer of Zeste homolog 2 during myogenesis. J Biol Chem. 283:9836–9843. 2008. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

November 2011
Volume 2 Issue 6

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Gao, J., & Gao, J. (2011). The role of miR-26 in tumors and normal tissues (Review). Oncology Letters, 2, 1019-1023. https://doi.org/10.3892/ol.2011.413
MLA
Gao, J., Liu, Q."The role of miR-26 in tumors and normal tissues (Review)". Oncology Letters 2.6 (2011): 1019-1023.
Chicago
Gao, J., Liu, Q."The role of miR-26 in tumors and normal tissues (Review)". Oncology Letters 2, no. 6 (2011): 1019-1023. https://doi.org/10.3892/ol.2011.413